PDE

Signaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S2131 Roflumilast <1 mg/mL 81 mg/mL 15 mg/mL
S1431 Sildenafil Citrate <1 mg/mL 20 mg/mL <1 mg/mL
S1455 Cilomilast <1 mg/mL 69 mg/mL 50 mg/mL
S1512 Tadalafil <1 mg/mL 78 mg/mL <1 mg/mL
S2515 Vardenafil HCl Trihydrate 10 mg/mL 100 mg/mL 20 mg/mL
S8459 TAK-063 <1 mg/mL 85 mg/mL <1 mg/mL
S1550 Pimobendan <1 mg/mL 67 mg/mL 5 mg/mL
S2620 GSK256066 <1 mg/mL 5 mg/mL <1 mg/mL
S2687 PF-2545920 <1 mg/mL 78 mg/mL 78 mg/mL
S1430 Rolipram <1 mg/mL 55 mg/mL 55 mg/mL
S1294 Cilostazol <1 mg/mL 74 mg/mL 6 mg/mL
S2484 Milrinone <1 mg/mL 42 mg/mL <1 mg/mL
S4019 Avanafil <1 mg/mL 97 mg/mL <1 mg/mL
S2127 S- (+)-Rolipram <1 mg/mL 55 mg/mL 55 mg/mL
S1673 Aminophylline 84 mg/mL 53 mg/mL <1 mg/mL
S3172 Anagrelide HCl <1 mg/mL 14 mg/mL <1 mg/mL
S1929 Irsogladine <1 mg/mL 2 mg/mL <1 mg/mL
S1504 Dyphylline 51 mg/mL 51 mg/mL <1 mg/mL
S1895 Dipyridamole <1 mg/mL 101 mg/mL 50 mg/mL
S4164 Doxofylline 24 mg/mL 53 mg/mL 2 mg/mL
S4090 Fenspiride HCl 59 mg/mL 9 mg/mL <1 mg/mL
S7224 Deltarasin <1 mg/mL 100 mg/mL 100 mg/mL
S2291 Diosgenin <1 mg/mL <1 mg/mL 83 mg/mL
S2312 Icariin <1 mg/mL 50 mg/mL <1 mg/mL
S4683 Sildenafil Mesylate 100 mg/mL 100 mg/mL 4 mg/mL
S4684 Sildenafil 14 mg/mL <1 mg/mL <1 mg/mL
S2320 Luteolin <1 mg/mL 57 mg/mL 3 mg/mL
S8218 PF-8380 <1 mg/mL 95 mg/mL <1 mg/mL
S2368 Theobromine <1 mg/mL <1 mg/mL <1 mg/mL

Isoform-specific Inhibitors

Catalog No. Information Product Use Citations Product Validations
S2131

Roflumilast

Roflumilast is a selective inhibitor of PDE4 with IC50 of 0.2-4.3 nM in a cell-free assay.

S1431

Sildenafil Citrate

Sildenafil Citrate, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), is a well-tolerated and highly effective treatment for erectile dysfunction.

S1455

Cilomilast

Cilomilast is a potent PDE4 inhibitor with IC50 of about 110 nM, has anti-inflammatory activity and low central nervous system activity. Phase 3.

S1512

Tadalafil

Tadalafil is a PDE-5 inhibitor with IC50 of 1.8 nM in a cell-free assay. Tadalafil is at least 9000 times more selective for PDE5 than most of the other families of PDEs, with the exception of PDE11. It can partial inhibits PDE11

S2515

Vardenafil HCl Trihydrate

Vardenafil HCl Trihydrate is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively.

S8459New

TAK-063

TAK-063 is a novel and selective phosphodiesterase 10A(PDE10A) inhibitor with an IC50 of 0.30 nM.

S1550

Pimobendan

Pimobendan is a selective inhibitor of PDE3 with IC50 of 0.32 μM.

S2620

GSK256066

GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selectivity against PDE4B versus PDE7.Phase 2.

S2687

PF-2545920

PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with >1000-fold selectivity over the PDE.

S1430

Rolipram

The PDE4 selective inhibitor, rolipram, inhibited immunopurified PDE4B and PDE4D activities similarly, with IC50 values of approx. 130 nM and 240 nM respectively; an anti-inflammatory agent.

S1294

Cilostazol

Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake.

S2484

Milrinone

Milrinone is a phosphodiesterase 3 (PDE3) inhibitor, used to increase the heart's contractility.

S4019

Avanafil

Avanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >121-fold selectivity over other PDEs.

S2127

S- (+)-Rolipram

S-(+)-Rolipram inhibits human monocyte cyclic AMP-specific PDE4 with IC50 of 0.75 μM, has anti-inflammatory and anti-depressant activity in the central nervous system, less potent than its R enantiomer.

S1673

Aminophylline

Aminophylline is a competitive nonselective phosphodiesterase inhibitor with an IC50 of 0.12 mM and also a nonselective adenosine receptor antagonist.

S3172

Anagrelide HCl

Anagrelide is a drug used for the treatment of essential thrombocytosis.

S1929

Irsogladine

Irsogladine is an anti-gastric ulcer agent that facilitates gap-junctional intercellular communication through M1 muscarininc acetylcholine receptor binding.

S1504

Dyphylline

Dyphylline is a xanthine derivative with bronchodilator and vasodilator effects.

S1895

Dipyridamole

Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.

S4164

Doxofylline

Doxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.

S4090

Fenspiride HCl

Fenspiride is a bronchodilator with anti-inflammatory properties, inhibiting phosphodiesterase 4 and phosphodiesterase 3 activities with logIC50 values of 4.16 and 3.44, respectively, in human isolated bronchi.

S7224

Deltarasin

Deltarasin is a small molecular inhibitor of KRAS-PDEδ interaction with Kd of 38 nM for binding to purified PDEδ.

S2291

Diosgenin

Diosgenin is a steroid sapogenin and the precursor for the semisynthesis of progesterone which in turn was used in early combined oral contraceptive pills; A weak PDE inhibitor.

S2312

Icariin

Icariin is a cGMP-specific PDE5 inhibitor with IC50 of 0.432 μM, 167-fold more selective for PDE5 than PDE4.

S4683

Sildenafil Mesylate

Sildenafil Mesylate is a mesylate form of Sildenafil, an inhibitor of Phosphodiesterase 5.

S4684

Sildenafil

Sildenafil is a Phosphodiesterase 5 Inhibitor with IC50 of 5.22 nM.

S2320

Luteolin

Luteolin is a flavonoid found in Terminalia chebula, which is a non-selective phisphodiesterase PDE inhibitor for PDE1-5 with Ki of 15.0 μM, 6.4 μM, 13.9 μM, 11.1 μM and 9.5 μM, respectively. Phase 2.

S8218

PF-8380

PF-8380 is a potent autotaxin inhibitor with IC50 of 2.8nM in an in vitro enzyme assay.

S2368

Theobromine

Theobromine is a xanthine alkaloid widely consumed as stimulants and snacks in coffee and cocoa based foods and most often as part of ingredients in drugs.